Clinical Trial Update: Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis Condition

View source ↗

Summary

A completed clinical trial update reports on participants' preferences among disease-modifying therapies for relapsing-remitting multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Multiple Sclerosis, Relapsing-Remitting | Status: COMPLETED